Projects funded by the NCN
New perspective in Alzheimer's disease therapy - multifunctional histamine H3 receptor ligands?
2016/23/B/NZ7/02327
Keywords:
histamine H3 receptor Alzheimer disease acetylcholinesterase butyrylcholinesterase monoamino oxidase B
Descriptors:
- NZ7_4: Prevention in population health
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- ST5_16:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 8
Call: OPUS 12 - announced on 2016-09-15
Amount awarded: 791 900 PLN
Project start date (Y-m-d): 2017-07-25
Project end date (Y-m-d): 2022-01-24
Project duration:: 54 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.